Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-22-000474
Filing Date
2022-10-06
Accepted
2022-10-06 08:37:08
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING AGIOS PHARMACEUTICALS, INC. AGIOS_PHARMACEUTICALS_INC..htm SC 13G/A 88004
  Complete submission text file 0000019617-22-000474.txt   89886
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Subject) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87570
SIC: 2834 Pharmaceutical Preparations